Mannatech Stock Price, News & Analysis

Mannatech (NASDAQ: MTEX) reported challenging second quarter 2025 financial results, with net sales declining to $25.7 million, down 7.4% from $27.7 million in Q2 2024. The company posted a significant net loss of $4.3 million ($2.27 per diluted share), compared to a loss of $0.6 million ($0.33 per share) in the same period last year.

Key financial metrics deteriorated across the board: gross profit margin decreased to 73.6% from 77.1%, cash and equivalents dropped 51.5% to $5.5 million, and the company's associate network shrunk to 125,000 from 142,000 year-over-year. The decline was attributed to weakened economic conditions in certain operating regions and increased operational costs.

Mannatech (NASDAQ: MTEX) has announced the promotion of Peter Griscom to Chief Operating Officer, effective July 1, 2025. Griscom, who has served as senior vice president of global operations since August 2024, brings over 10 years of experience in direct selling and extensive expertise in consumer goods.

Prior to his current role, Griscom served as senior vice president of product, innovation, & supply chain. He holds degrees from the University of Auburn and the University of Utah. CEO Landen Fredrick highlighted Griscom's ability to create operational efficiencies and streamline processes as key factors in reducing costs and advancing the company.

Mannatech (NASDAQ: MTEX) held its annual shareholder meeting on June 3, 2025, where shareholders approved all proposed items. With 77.8% of shares represented (1,478,342 out of 1,900,930 outstanding shares), shareholders elected J. Stanley Fredrick and Tyler J. Rameson as Class II Directors to serve until 2028. The meeting, chaired by J. Stanley Fredrick, included approval of BDO USA, P.C. as the independent auditor for FY2025, endorsement of executive compensation, and a decision on the frequency of future compensation votes, with a majority favoring annual voting (774,408 shares for 1-year option vs 280,406 for 3-year option).

Mannatech (MTEX) has premiered "Steve Edwards: The Long Run", an 11-minute documentary showcasing the remarkable journey of marathon legend Steve Edwards. The film, available on events.mannatech.com and Facebook, highlights Edwards' achievement of completing over 1,000 official marathons with an impressive average time of 3 hours, 21 minutes, and 47 seconds. Edwards credits Mannatech's Glycan Replenishment Therapy, particularly Ambrotose Life® powder, for supporting his recovery, training, and athletic longevity into his 60s. The documentary, produced by Jim Fabio of True Blue Creative, includes an exclusive interview where Edwards discusses his nutritional protocol and training mindset.

Mannatech (NASDAQ: MTEX) reported challenging Q1 2025 financial results, with net sales declining 9.6% to $26.6 million compared to $29.4 million in Q1 2024. The company swung to a net loss of $1.5 million ($0.80 per share) from a net income of $1.2 million ($0.63 per share) year-over-year. Key challenges included weakened demand in Asia, increased freight costs, and reduced gross margins to 74.3% from 78.6%. Cash position deteriorated with cash and equivalents dropping 18.2% to $9.3 million. The company's network shrunk with associate and preferred customer positions decreasing to 129,000 from 143,000, while recruiting declined 13.9% compared to Q1 2024.

Mannatech (NASDAQ: MTEX) reported its Q4 2024 financial results, showing mixed performance. Fourth quarter net sales decreased 11.3% to $29.0 million compared to $32.7 million in Q4 2023, with a 9.2% decline on a constant dollar basis.

Despite lower sales, the company improved its gross profit margin to 80.5% (vs 75.4% in Q4 2023) and reduced selling and administrative expenses by $1.7 million. Q4 2024 operating income was $0.9 million, compared to a $0.9 million loss in Q4 2023. Net income reached $2.3 million ($1.20 per diluted share), versus a net loss of $1.8 million in Q4 2023.

For full-year 2024, net sales declined 10.7% to $117.9 million. The company's network decreased to 133,000 associates and preferred customers (from 145,000 in 2023), with recruiting down 19.5%. Despite challenges, Mannatech achieved a net income of $2.5 million ($1.32 per diluted share) in 2024, compared to a $2.2 million loss in 2023, while cash position improved to $11.4 million.

Mannatech (NASDAQ: MTEX) has appointed Robert A. Toth as Vice Chairman of the Board effective December 1, 2024. Toth, who previously served on the company's board from 2008 to 2023, brings over 40 years of direct selling experience, including his role as President of Avon International where he managed operations in over 120 countries with annual revenues exceeding $5.5 billion. During his previous tenure at Mannatech, he served on multiple committees and as Vice Chairman from 2014 to 2019. The appointment aims to leverage his extensive international experience for global expansion strategies.

Mannatech (NASDAQ: MTEX) reported Q3 2024 financial results with net sales of $31.7 million, down 2.5% from $32.6 million in Q3 2023. Gross profit margin decreased to 74.5% from 79.6%. The company reported an operating income of $0.9 million, up from $0.2 million last year, despite revenue decline mainly due to reduced demand in Asia. Net loss was $0.3 million ($0.17 per share) compared to net income of $18,000 ($0.01 per share) in Q3 2023. Cash position improved to $12.2 million, up 57.2% from December 2023. The company's network decreased to 136,000 associates and preferred customers from 146,000 in 2023.

Mannatech (NASDAQ: MTEX) reported financial results for Q2 2024, showing a 14.9% decrease in net sales to $27.7 million compared to $32.6 million in Q2 2023. The decline was attributed to supply chain constraints, back orders, and weakening economic conditions in Asia. Gross profit margin decreased to 77.1% from 78.5% year-over-year. The company reported a net loss of $0.6 million, or $0.33 per diluted share, compared to a net loss of $1.1 million, or $0.59 per diluted share in Q2 2023. Despite challenges, Mannatech's cash position improved, with cash and cash equivalents increasing by 18.9% to $9.2 million as of June 30, 2024.